Litigation Details for Pfizer Inc. v. Aurobindo Pharma USA Inc. (D. Del. 2017)
✉ Email this page to a colleague
Pfizer Inc. v. Aurobindo Pharma USA Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-12-07 |
Court | District Court, D. Delaware | Date Terminated | 2018-05-31 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 6,124,363 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Pfizer Inc. v. Aurobindo Pharma USA Inc.
Details for Pfizer Inc. v. Aurobindo Pharma USA Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-12-07 | 1 | Aurobindo for patent infringement of United States Patent No. 6,124,363 (the “’363 patent”) arising from…BACKGROUND The ’363 Patent 11. On September 26, 2000, the United States Patent and Trademark Office…) issued the ’363 patent, titled “Dofetilide Polymorphs.” A copy of the ’363 patent is attached hereto…363 patent. 23. On information and belief, Aurobindo had knowledge of the ’363 patent when…the ’363 patent. Aurobindo’s ANDA Products will infringe at least claim 1 of the ’363 patent. | External link to document | |
2018-07-20 | 14 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number 6,124,363. (etg) (Entered: 07/… 2017 31 May 2018 1:17-cv-01775 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2017-12-07 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,124,363. (nmfn) (Entered: 12… 2017 31 May 2018 1:17-cv-01775 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |